PL02.3.A NRG ONCOLOGY STUDY BN007: RANDOMIZED PHASE II/III TRIAL OF IPILIMIUMAB (IPI) PLUS NIVOLUMAB (NIVO) VS. TEMOZOLOMIDE (TMZ) IN MGMT-UNMETHYLATED (UMGMT) NEWLY DIAGNOSED GLIOBLASTOMA (NGBM)Andrew B. Lassman, Mei‐Yin C. Polley,Fabio Iwamoto,Andrew E. Sloan,Tony J. C. Wang,Kenneth Aldape, J.S. Wefel,Vinai Gondi,Alonso N. Gutiérrez,Mohammed Manasawala,Mark R. Gilbert,Erik P. Sulman,J D Wolchok, Robert M. Greene,Elizabeth Neil,Rimas V. Lukas,Samuel Goldlust,Matija Snuderl,James J. Dignam,Minhee Won,Benjamin Movsas,Minesh P. MehtaNeuro-oncology（2023）引用 0|浏览39暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
